ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

8.500 +0.425 (+5.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 2,459,226
Open 8.140
Bid (Size) 8.320 (2)
Ask (Size) 8.460 (1)
Prev. Close 8.075
Today's Range 8.025 - 8.515
52wk Range 5.900 - 28.18
Shares Outstanding 88,140,978
Dividend Yield N/A

Performance

YTD
-30.4%
-30.4%
1 Month
+23.9%
+23.9%
3 Month
-20.6%
-20.6%
6 Month
-39.2%
-39.2%
1 Year
-67.5%
-67.5%

More News

Read More

Frequently Asked Questions

Is Intellia Therapeutics, Inc. - Common Stock publicly traded?
Yes, Intellia Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Intellia Therapeutics, Inc. - Common Stock trade on?
Intellia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Intellia Therapeutics, Inc. - Common Stock?
The ticker symbol for Intellia Therapeutics, Inc. - Common Stock is NTLA on the Nasdaq Stock Market
What is the current price of Intellia Therapeutics, Inc. - Common Stock?
The current price of Intellia Therapeutics, Inc. - Common Stock is 8.500
When was Intellia Therapeutics, Inc. - Common Stock last traded?
The last trade of Intellia Therapeutics, Inc. - Common Stock was at 05/16/25 04:00 PM ET
What is the market capitalization of Intellia Therapeutics, Inc. - Common Stock?
The market capitalization of Intellia Therapeutics, Inc. - Common Stock is 749.20M
How many shares of Intellia Therapeutics, Inc. - Common Stock are outstanding?
Intellia Therapeutics, Inc. - Common Stock has 749M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.